The emerging treatment of the medication represents a major development in the management of type 2 diabetes. Unlike existing medications, tirzepatide affects dual pathways – glucagon-like peptide-1 (GLP-1) and GIP https://tirzepatide-peptide991268.get-blogging.com/42511872/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment